Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,449 | 0 | 0 | N/A | 0 |
| Other current assets | 2,011 | 0 | 0 | 0 | 0 |
| TOTAL | $38,874 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 980 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 14,870 | 0 | 0 | 0 | 0 |
| TOTAL | $15,850 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $54,724 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,147 | 0 | 0 | N/A | 0 |
| Accounts payable and accrued liabilities | 2,655 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 13,620 | 0 | 0 | N/A | 0 |
| TOTAL | $23,035 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 193,146 | 0 | 0 | 0 | 0 |
| TOTAL | $194,497 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $217,532 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,646 | N/A | N/A | N/A | N/A |
| Retained earnings | -167,653 | 0 | 0 | N/A | 0 |
| TOTAL | $-162,808 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $54,724 | $0 | $0 | $0 | $0 |